האמט פי 250IU FVIII 600IU VWF

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

FACTOR VIII (HUMAN); VON WILLEBRAND FACTOR

MAH:

CSL BEHRING LTD., ISRAEL

ATC_code:

B02BD02

pharmaceutical_form:

אבקה וממס להכנת תמיסה להזרקה\אינפוזיה

composition:

FACTOR VIII (HUMAN) 250 IU / 5 ML; VON WILLEBRAND FACTOR 600 IU / 5 ML

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

CSL BEHRING GMBH, GERMANY

therapeutic_group:

COAGULATION FACTOR VIII

therapeutic_area:

COAGULATION FACTOR VIII

therapeutic_indication:

Congenital and acquired deficiency of blood clotting factor VIII: severe or moderate haemophilia, prophylaxis during operation, Von Willebrand's disease.

authorization_date:

2014-02-28